RDUS On Other Exchanges

radius health inc (RDUS) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for RADIUS HEALTH INC (RDUS)

Related News

No related news articles were found.

radius health inc (RDUS) Related Businessweek News

No Related Businessweek News Found

radius health inc (RDUS) Details

Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company markets TYMLOS for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide transdermal patch, a short-wear-time patch formulation of abaloparatide to treat postmenopausal women with osteoporosis; RAD1901, a selective estrogen receptor down-regulator for the treatment of metastatic breast cancer; and RAD140, a non-steroidal selective androgen receptor modulator to treat breast cancer. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Eisai Co. Ltd.; Duke University; and Teijin Limited. Radius Health, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

379 Employees
Last Reported Date: 05/8/19
Founded in 2003

radius health inc (RDUS) Top Compensated Officers

President, CEO & Director
Total Annual Compensation: $1.0M
CFO, Senior VP & Treasurer
Total Annual Compensation: $673.5K
Chief Medical Officer
Total Annual Compensation: $414.1K
Total Annual Compensation: $580.2K
Senior Vice President of Sales & Marketing
Total Annual Compensation: $654.3K
Compensation as of Fiscal Year 2018.
radius health inc
Radius Health, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-16-2019 09:20 AM

Radius Health, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-16-2019 09:20 AM. Venue: Encore Hotel, Wynn, Las Vegas, Nevada, United States. Speakers: Joe Kelly, Senior Vice President of Sales and Marketing, Pepe Carmona, Chief Financial Officer.

Radius Health, Inc. Revises Revenue Guidance for the Full Year 2019

Radius Health, Inc. revised its revenue guidance for the full year 2019. For the period, the company now expects net sales of $160 million to $175 million as compared to its previous guidance range of $155 million to $175 million.

Radius Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019

Radius Health, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced operating loss was USD 37.831 million compared to USD 57.617 million a year ago. Net loss was USD 42.760 million compared to USD 61.555 million a year ago. Basic loss per share was USD 0.94 compared to USD 1.37 a year ago.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

RDUS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RDUS.
View Industry Companies

Industry Analysis


Industry Average

Valuation RDUS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.8x
Price/Book 36.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.4x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact RADIUS HEALTH INC, please visit www.radiuspharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.